Literature DB >> 33891709

FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.

Musa Yilmaz1, Naval Daver1, Gautam Borthakur1, Tapan Kadia1, Courtney DiNardo1, Rashmi Kanagal-Shamanna2, Sanam Loghavi2, Betul Oran3, Uday R Popat3, Sherry Pierce1, Elias Jabbour1, Nicholas J Short1, Ghayas Issa1, Maro Ohanian1, Marina Konopleva1, Keyur Patel2, Hagop Kantarjian1, Farhad Ravandi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33891709      PMCID: PMC9154045          DOI: 10.1002/ajh.26202

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   13.265


× No keyword cloud information.
  1 in total

1.  Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.

Authors:  Konstanze Döhner; Christian Thiede; Nikolaus Jahn; Ekaterina Panina; Agnes Gambietz; Richard A Larson; Thomas W Prior; Guido Marcucci; Dan Jones; Jürgen Krauter; Michael Heuser; Maria Teresa Voso; Tiziana Ottone; Josep F Nomdedeu; Sumithra J Mandrekar; Rebecca B Klisovic; Andrew H Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Joop H Jansen; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Insa Gathmann; Axel Benner; Celine Pallaud; Richard M Stone; Hartmut Döhner; Clara D Bloomfield
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.